ClinicalTrialsFinder

Advanced Triple Negative Breast Cancers Clinical Trials in Singapore

1 recruitingSingapore, Singapore

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

Advanced Refractory Solid TumorsAdvanced Triple Negative Breast CancersMetastatic Triple Negative Breast Cancers
National University Hospital, Singapore63 enrolled1 locationNCT05035745